Your browser does not support javascript:   Search for gard hereSearch for news-and-events here.


Outcome Measures for Clinical Trials in Children with Fragile X Syndrome – Part II

Thursday, November 05, 2009 - Friday, November 06, 2009
Bethesda Marriott Pooks Hill, Bethesda, MD

The goals of the first meeting were to (1) describe outcome measures for safety and efficacy when treating children with FXS, (2) assess validation of those measures for clinical studies, and (3) describe approaches for preclinical toxicology studies to define efficacy and safety.

Tiina K. Urv, Ph.D., NICHD (301) 402-7015

Co-funding Institute(s):
National Institute of Child Health and Human Development

From the National Center for Advancing Translational Sciences

From the National Institutes of Health

Connect with ORDR

See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.